Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia

Published:2023-09-21 Issue:14 Volume:64 Page:2316-2323
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Huntington Scott F.¹,Manzoor Beenish S.²,Puckett Justin T.³,Kamal-Bahl Sachin³,Alhasani Hasan²,Ravelo Arliene⁴,Jawaid Dureshahwar²,Doshi Jalpa A.⁵

Affiliation:

1. Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA

2. AbbVie Inc, North Chicago, IL, USA

3. COVIA Health Solutions, Lansdale, PA, USA

4. Genentech Inc, South San Francisco, CA, USA

5. Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Funder

AbbVie Inc

Genentech Inc

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2255326

Reference21 articles.

1. Chronic lymphocytic leukaemia

2. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

3. Prognostic markers and standard management of chronic lymphocytic leukemia

4. Management of chronic lymphocytic leukemia

5. Advances in chronic lymphocytic leukemia pharmacotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP